Related Experiment Video
Updated: Oct 2, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases
Holger Lorenz1, Otto Windl, Hans A Kretzschmar
1Institut für Neuropathologie, Ludwig-Maximilians-Universität München, D-81377 München, Germany.
Abstract:
The pathogenic mechanisms leading from mutations in the prion protein (PrP) gene to infectious disease are not understood. To investigate the possibility that cellular processing of mutant prion protein may contribute to the formation of infectious particles, a mouse PrP model system has been established using the green fluorescent protein. Three novel PrP mutants were examined employing this model system and compared with wild type as well as known mutant PrPs. Two Creutzfeldt-Jakob disease-associated PrP mutants, PrP T188K and PrP T188R, revealed a secretory pathway to the cell membrane and PrP(Sc)-like properties, i.e. enhanced proteinase K resistance and detergent insolubility similar to other mutant PrPs associated with familial prion diseases. Moreover, a recently described disease-related truncated PrP mutant, PrP Q160(Stop), showed an almost exclusive localization in the nucleus and a catabolism along the proteasomal pathway. Therefore, various distinct pathological mechanisms may cause prion diseases, and aberrant cellular processing may be included in the pathogenesis of prion diseases.
Insights
Mutant prion protein (PrP) processing may cause infectious prion diseases. Aberrant cellular pathways for PrP mutants, like those in Creutzfeldt-Jakob disease, contribute to disease pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Pathogenic mechanisms of prion protein (PrP) gene mutations remain unclear.
- Investigating cellular processing of mutant PrP for infectious particle formation is crucial.
Purpose of the Study:
- To explore how cellular processing of mutant prion protein contributes to prion disease pathogenesis.
- To examine novel PrP mutants using a mouse PrP model.
Main Methods:
- Established a mouse PrP model using green fluorescent protein.
- Examined three novel PrP mutants, comparing them to wild-type and known mutants.
- Assessed PrP localization, proteinase K resistance, and detergent insolubility.
Main Results:
- Two Creutzfeldt-Jakob disease-associated mutants (PrP T188K, PrP T188R) showed secretory pathway localization and PrP(Sc)-like properties.
- A truncated PrP mutant (PrP Q160(Stop)) localized to the nucleus and was degraded via the proteasomal pathway.
- Mutant PrPs exhibited enhanced proteinase K resistance and detergent insolubility.
Conclusions:
- Distinct pathological mechanisms likely underlie prion diseases.
- Aberrant cellular processing of prion protein is implicated in prion disease pathogenesis.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents

